Material and Methods: 226 patients, 38 female and 188 male, with head and neck cancer, treated with chemoradiotherapy from 1995 to 2014 at our department, were retrospectively reviewed. 59,7% of patients were younger than 60 years. The anatomical sites of cancer were: 36 nasopharynx, 63 oropharynx, 34 oral cavity, 51 larynx, 26 hypopharynx, 16 others sites. 64 patients underwent to postoperative treatment and 162 to radical treatment. They were treated with 2D-3DCRT (80%) or IMRT technique (20%). The mean dose administered was 68 Gy (range 60-74). The schedule of chemotherapy most used included cisplatin and 5-FU. Acute and late toxicity are assessed according to CTCAE v.4.0 scale. Age, gender, tumor/nodal stage, primary site, tumor grading, RT technique and dose were assessed as potential prognostic factors influencing treatment toxicity.
Conclusion:
Clinical and technical data may be predictive of severe toxicity. Younger patients with pharynx cancer are more susceptible to dysphagia, mucositis and xerostomia. In this subset of patients it's critical evaluate strategies of adaptive radiotherapy with the aim to decrease the toxicity. , the stage of T (T1+T2+T3 vs T4) was found to be a prognostic factor for LRC (p = 0.035). Both at univariate and multivariate analysis the stage of T was found to be a prognostic factor for LC (p = 0.004 and .011 respectively) and N stage (N0+N1+N2 vs N3) for DM and RC. Pts with a V95% > 90% had better LC (p= 0.004) and DFS (p= 0.047). Pts with a Dmean > 69 Gy had better LC (p=0.029). Pts with a D99% > 64 Gy had better LC (p=0.008) and OS (p=0.004). The threshold value of 45 cc of GTV T (Gross Tumor Volume of the primary tumor) was prognostic for LC (p = 0.0095). The threshold value of 1500 copies of EBV-DNA was prognostic for DC (p = 0.048).
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Conclusion:
The intensified treatment of CT-IMRT / VMAT achieves excellent clinical outcomes. Besides traditional prognostic factors, we demonstrated the prognostic value of dosimetric parameters. Finally, for the first time in a nonendemic area threshold values of GTV T and EBV-DNA prognostic for LC and DC respectively have been confirmed. 
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